SikkensEC, CahenDL, de WitJ, et al.A prospective assessment of the natural course of the exocrine pancreatic function in patients with a pancreatic head tumor. J Clin Gastroenterol, 2014; 48(5):e43–e46; doi: 10.1097/MCG.0b013e31829f56e7
2.
RobertsK, BannisterC, SchremH. Enzyme replacement improves survival among patients with pancreatic cancer: Results of a population-based study. Pancreatology, 2019; 19(1):114–121; doi: 10.1016/j.pan.2018.10.010
3.
VujasinovicM, ValenteR, Del ChiaroM, et al.Pancreatic exocrine insufficiency in pancreatic cancer. Nutrients, 2017; 9(3):183; doi: 10.3390/nu9030183
4.
PortaM, FabregatX, MalatsN, et al.Exocrine pancreatic cancer: Symptoms at presentation and their relation to tumor site and stage. Clin Transl Oncol, 2005; 7(5):189–197; doi: 10.1007/BF02712816
5.
CarnieLE, LamarcaA, McNamaraMG, et al.The assessment of pancreatic exocrine function in patients with inoperable pancreatic cancer: In need of a new gold-standard. Pancreatology, 2020; 20(4):668–675; doi: 10.1016/j.pan.2020.03.020
6.
DamerlaV, GotliebV, LarsonH, et al.Pancreatic enzyme supplementation in pancreatic cancer. J Support Oncol, 2008; 6(8):393–396.
7.
LoserC, MollgaardA, FolschUR. Fecal elastase 1: A novel, highly sensitive, and specific tubeless pancreatic function test. Gut, 1996; 39(4):580–586; doi: 10.1136/gut.39.4.580
8.
MuñozJED. Diagnosis of chronic pancreatitis: Functional testing. Best Pract Res Clin Gastroenterol, 2010; 24:233–241; doi: 10.1016/j.bpg.2010.03.008
9.
BalabanEP, ManguPB, KhoranaAA, et al.Locally advanced, unresectable pancreatic cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol, 2016; 34(22):2654–2668; doi: 10.1200/JCO.2016.67.5561
HammerHF. Pancreatic exocrine insufficiency: Diagnostic evaluation and replacement therapy with pancreatic enzymes. Dig Dis, 2010; 28(2):339–343; doi: 10.1159/000319411
12.
GoodenHM, WhiteKJ. Pancreatic cancer and supportive care—Pancreatic exocrine insufficiency negatively impacts on quality of life. Support Care Cancer, 2013; 21(7):1835–1841; doi: 10.1007/s00520-013-1729-3
13.
GarciaMA, BraunU, BeardenD, et al.Appropriate use of pancreatic enzymes in veterans with pancreatic cancer. J. Pain Symptom Manag, 2022; 63(6):1149; doi: 10.1016/j.jpainsymman.2022.04.158
TrapnellBC, MaguinessK, GraffGR, et al.Efficacy and safety of Creon 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis. J Cyst Fibros, 2009; 8(6):370–377; doi: 10.1016/j.jcf.2009.08.008
